Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI.
Tanaka E, Yamazaki H, Yoshida K, Takenaka T, Masuda N, Kotsuma T, Yoshioka Y, Inoue T. Tanaka E, et al. Among authors: masuda n. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1098-104. doi: 10.1016/j.ijrobp.2010.07.035. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932653
Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306.
Mukai H, Watanabe T, Mitsumori M, Tsuda H, Nakamura S, Masuda N, Yamamoto N, Shibata T, Sato A, Iwata H, Aogi K. Mukai H, et al. Among authors: masuda n. Oncology. 2013;85(6):336-41. doi: 10.1159/000355196. Epub 2013 Nov 12. Oncology. 2013. PMID: 24247597 Clinical Trial.
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
Inoue K, Kuroi K, Shimizu S, Rai Y, Aogi K, Masuda N, Nakayama T, Iwata H, Nishimura Y, Armour A, Sasaki Y. Inoue K, et al. Among authors: masuda n. Int J Clin Oncol. 2015 Dec;20(6):1102-9. doi: 10.1007/s10147-015-0832-5. Epub 2015 May 13. Int J Clin Oncol. 2015. PMID: 25967286 Free PMC article. Clinical Trial.
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance.
Otani Y, Nose T, Dokiya T, Saeki T, Kumazaki Y, Asahi S, Tsukiyama I, Fukuda I, Sekine H, Shikama N, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Yoden E, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M. Otani Y, et al. Among authors: masuda n. Radiat Oncol. 2015 Jun 4;10:126. doi: 10.1186/s13014-015-0430-8. Radiat Oncol. 2015. PMID: 26040632 Free PMC article. Clinical Trial.
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: clinical results with a median follow-up of 26 months.
Nose T, Otani Y, Asahi S, Tsukiyama I, Dokiya T, Saeki T, Fukuda I, Sekine H, Shikama N, Kumazaki Y, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Yoden E, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M. Nose T, et al. Among authors: masuda n. Breast Cancer. 2016 Nov;23(6):861-868. doi: 10.1007/s12282-015-0652-5. Epub 2015 Oct 14. Breast Cancer. 2016. PMID: 26467037 Clinical Trial.
1,204 results